Internal Medicine, Endocrinology, Diabetes, & Metabolism · Boston, MA
NPI
1528119591
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
55 Fruit St
Boston, MA, 02114
Phone (617) 724-3782
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,036
96 services
Medicare patients, 2024
52
Average age 70
Drug cost, 2024
$127K
348 prescriptions
Company payments, 2025
$15K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anand Vaidya was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 32 times for 28 patients. In total Anand Vaidya billed 96 services in 11 codes, and Medicare paid $6,036.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-01.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 32 | 28 | $13.62 | $436 |
| 99214 Office E&M - Established | Office | 31 | 30 | $71.08 | $2,203 |
By year: 2022 $9,807 for 113 services; 2023 $11K for 106 services; 2024 $6,036 for 96 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anand Vaidya prescribed most often to Medicare patients was Hydrocortisone, with 69 prescriptions and refills. In total Anand Vaidya wrote 348 Medicare prescriptions that cost $127K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocortisone Generic | 69 | 164 | 18 | $3,335 |
| Fludrocortisone Acetate Generic | 57 | 163 | 16 | $1,003 |
| Lysodren Mitotane | 38 | 46 | Under 11 | $106K |
| Levothyroxine Sodium Generic | 35 | 105 | Under 11 | $363 |
| Eplerenone Generic | 23 | 53 | Under 11 | $3,815 |
| Spironolactone Generic | 22 | 60 | Under 11 | $150 |
| Amlodipine Besylate Generic | 16 | 48 | Under 11 | $66.28 |
| Alendronate Sodium Generic | 13 | 36 | Under 11 | $96.08 |
Brand drugs: 73 claims; generic drugs: 275 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anand Vaidya $15K ($15K in general payments such as food, travel and fees) from 5 companies. The largest payer was AstraZeneca UK Limited with $8,056.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.